NIH Toolbox for Assessment of Neurological and Behavioral Function - NIH Toolbox Standing Balance Test Age 7+ v2.0

COA At-a-Glance

Evidence of cognitive interviewing of draft instrument in target patient population

Evidence of internal consistency

Evidence of test-retest or inter-rater reliability

Evidence of concurrent validity

Evidence of known-groups validity

Evidence of ability to detect change over time

Evidence of responder thresholds

Inclusion of the COA in product labelling

Daily function
Gross motor function

Overview

Instrument Name: NIH Toolbox for Assessment of Neurological and Behavioral Function - NIH Toolbox Standing Balance Test Age 7+ v2.0

Abbreviation: NIH Toolbox Standing Balance Test Age 7+ v2.0

Points for Consideration:

Little data available

Description of Tool:

The NIH Toolbox Standing Balance Test Age 7+ v2.0 is a PerfO assessing a child (or adult) in 5 standing positions. Each test is rated as pass/fail, with lower scores representing better performance.

Minimum Qualification Required by COA Administrator: MA or BA

Comment:

The NIH Toolbox Standing Balance Test Age 7+ v2.0 is a specific test within the NIH Toolbox Balance
The NIH Toolbox Balance is a subdomain within the NIH Toolbox Motor Battery

Year: 2013

Objective of Development:

To measure motor function across the age span from 7+ to 85 years, with a focus on balance

Population of Development: Age range (therapeutic indication):

7-85 years (All)

Pediatric Population(s) in which COA has been used:

Female Urogenital Diseases and Pregnancy Complications; Wounds and Injuries

COA type:

Number of Items 5

Mode of Administration:

Data Collection Mode:

Time for Completion: 7 minutes

Response Scales: Dichotomous: Pass or Fail

Summary of Scoring:

Available Scores:
Global Score
Scores by domains
Scores by items
Cutoff score: <2 SDs below the mean (score <30) is suggestive of motor dysfunction Weighting: No Score Interpretation: Lower score = Better performance


Content Validity

Evidence of Literature Review: Yes

Evidence of Instrument Review: Yes

Evidence of Clinical or Expert Input: Yes

Evidence of concept elicitation in target patient population: None identified

Evidence of a Saturation Grid: Not applicable

Evidence for Selection of Data Collection Method: None identified

Recall/Observation Period:

Evidence for Selection of Reponse Options: None identified

Evidence of cognitive interviewing of draft instrument in target patient population: None identified

Evidence of Preliminary Scoring of Items and Domains: Not applicable

Evidence related to respondent and administrator burden: None identified

Evidence of a Conceptual Framework: None identified

Evidence of an item-tracking matrix: Not applicable

Evidence related to item selection: Not applicable

Evidence of re-testing the final version: Yes


Reliability

Internal consistency (Cronbach's alpha): Not applicable

Test-retest Reliability (ICC):

Rine RM (2013)
1- Intraclass Correlation Coefficient (ICC): ranged from 0.82 to 0.97
- Was a definition of stability applied to identify stable patients: No
- Time frame or interval between the two administrations: 25 minutes
- Population/Disease: Children of 8.6 to 17 years; n=62

2- Intraclass Correlation Coefficient (ICC): ranged from 0.33 to 0.79
- Was a definition of stability applied to identify stable patients: No
- Time frame or interval between the two administrations: 25 minutes
- Population/Disease: Patients of 18 to 35 years; n=31

3- Intraclass Correlation Coefficient (ICC): ranged from 0.73 to 0.89
- Was a definition of stability applied to identify stable patients: No
- Time frame or interval between the two administrations: 25 minutes
- Population/Disease: Patients of 36 to 65 years; n=41

4- Intraclass Correlation Coefficient (ICC): ranged from 0.86 to 0.97
- Was a definition of stability applied to identify stable patients: No
- Time frame or interval between the two administrations: 25 minutes
- Population/Disease: Patients of 66 to 85 years; n=29

5- Intraclass Correlation Coefficient (ICC): ranged from 0.82 to 0.97
- Was a definition of stability applied to identify stable patients: No
- Time frame or interval between the two administrations: 25 minutes
- Population/Disease: Patients of 3 to 17 years; n=107

6- Intraclass Correlation Coefficient (ICC): ranged from 0.74 to 0.86
- Was a definition of stability applied to identify stable patients: No
- Time frame or interval between the two administrations: 25 minutes
- Population/Disease: Patients of 18 to 85 years; n=101

Marchetti GF (2013)
1- Intraclass Correlation Coefficient (ICC): ranged from 0.74 to 0.86
- Was a definition of stability applied to identify stable patients: No
- Time frame or interval between the two administrations: 15 minutes
- Population/Disease: Healthy patients; n ranged from 78 to 84

2- Intraclass Correlation Coefficient (ICC): ranged from 0.46 to 0.87
- Was a definition of stability applied to identify stable patients: No
- Time frame or interval between the two administrations: 15 minutes
- Population/Disease: Patients with vestibular disorder; n ranged from 9 to 17

Inter-rater/ inter-interviewer reliability (kappa):

Not applicable

Evidence of test-retest or inter-rater reliability: Yes


Validity

Concurrent validity (convergent, divergent):

Rine RM (2013)
- Correlation coefficient used: Spearman Nonparametric correlation coefficient
- Measure: Sensory Organization Testing (SOT) condition 5
- Results:
Information Not specified for the share of the population aged 7+ in the child population
Significant correlations were found between the SOT condition 5 and the BAM 4
Children: r= -0.48; p= 0.04
Adults: r= -0.42; p= 0.01
- Population/Disease: Healthy and patients with vestibular disorder ; n= about 202 to 208, aged between 7-85

Known-group validity:

Rine RM (2013)
1. Measure/Groups of patients: Center of Pressure (COP)
- A priori hypotheses: COP would correlate with NPL scores
- Were hypotheses confirmed: Yes
- Results: Pearson's correlation coefficient:
Information Not specified for the share of the population aged 7+ in the child population
Correlations were found between NPL scores and COP:
Children: r= 0.42 to 0.85
Adults: r= 0.42 to 0.70
- Population/Disease: Healthy and patients with vestibular disorder ; n= about 202 to 208, aged between 7-85 years

KNown-groups validity:
2. Measure/Groups of patients: Healthy (n= below 184) and patients with vestibular disorder (n=between 18 to 24)
- A priori hypotheses: Normalized Path Length (NPL) scores would be different between groups
- Were hypotheses confirmed: Yes
- Results: t-test : data Not shown
Information Not specified for the share of the population aged 7+ in the child population
NPL scores were significantly different between healthy and patients with vestibular disorder:
BAM 2: p=0.02
BAM 5: p=0.04
- Population/Disease: Healthy and patients with vestibular disorder ; n= about 202 to 208, aged between 7-85 years

Marchetti GF (2013)
KNown-groups validity:
3. Measure/Groups of patients: Healthy (n=84) and patients with vestibular disorder (n=17)
- A priori hypotheses: Mean composite score would be different between groups
- Were hypotheses confirmed: Yes
- Results: Mean composite score (SD)
Healthy: 19.6 (15.3)
Patients with vestibular disorder: 36.6 (20.3)
- Population/Disease: Healthy and patients with vestibular disorder ; n= 101 aged between 8.5 to 85 years

Evidence of Translatability Assessment: None identified

Evidence related to missing data: None identified

Evidence for Selection of Recall Period: None identified

Evidence of Administration Instructions and Training Provided: None identified

Evidence of concurrent validity: Yes

Evidence of known-groups validity: Yes

Evidence of ability to detect change over time: None identified


Ability to Detect Change

Ability to detect change (Responsiveness):

None identified


Responder Thresholds

Evidence of responder thresholds: None identified


Reference(s) of development / validation

Reuben DB, Magasi S, McCreath HE, BohanNon RW, Wang YC, Bubela DJ, Rymer WZ, Beaumont J, Rine RM, Lai JS, Gershon RC. Motor assessment using the NIH Toolbox. Neurology. 2013 Mar 12;80(11 Suppl 3):S65-75
(Full Text Article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662336/pdf/WNL204799.pdf)

Rine RM, Schubert MC, Whitney SL, Roberts D, Redfern MS, MusoliNo MC, Roche JL, Steed DP, Corbin B, Lin CC, Marchetti GF, Beaumont J, Carey JP, Shepard NP, Jacobson GP, Wrisley DM, Hoffman HJ, Furman G, Slotkin J. Vestibular function assessment using the NIH Toolbox. Neurology. 2013 Mar 12;80(11 Suppl 3):S25-31
(Full Text Article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662339/)

Marchetti GF, Bellanca J, Whitney SL, Lin JC, MusoliNo MC, Furman GR, Redfern MS. The development of an accelerometer-based measure of human upright static anterior- posterior postural sway under various sensory conditions: test-retest reliability, scoring and preliminary validity of the Balance Accelerometry Measure (BAM). J Vestib Res. 2013;23(4-5):227-35
(PubMed Abstract https://pubmed.ncbi.nlm.nih.gov/24284603/


Other references

HealthMeasures website: https://www.healthmeasures.net/explore-measurement-systems/nih-toolbox


Inclusion of the COA in product labelling

None identified


Existence of Scoring / Interpretation / User Manual


Original language and translations

Original language: English for the USA

Translations:
Spanish


References of translations

None identified


Authors and contact information

Authors:
Reuben DB, Magasi S, McCreath HE, BohanNon RW, Wang YC, Bubela DJ, Rymer WZ, Beaumont J, Rine RM, Lai JS, Gershon RC

Contact:
National Institute of Health (NIH)
E-mail: cognition@nihtoolbox.org


Website

Health Measures website (http://www.healthmeasures.net/explore-measurement-systems/nih-toolbox/obtain-and-administer-measures)


Review copy

Review copy available here (http://www.healthmeasures.net/index.php?Itemid=992)